Price
Frequently asked questions
What is Bio Rad's market capitalization?
What is the Earnings Per Share (EPS) for Bio Rad?
What are the analyst ratings and target price for Bio Rad's stock?
What is Bio Rad's revenue over the trailing twelve months?
What is the EBITDA for Bio Rad?
What is the free cash flow of Bio Rad?
What is the 5-year beta of Bio Rad's stock?
How many employees does Bio Rad have, and what sector and industry does it belong to?
What is the free float of Bio Rad's shares?
Financials
Market Cap
$9.16B5Y beta
0.90EPS (TTM)
-$27.32Free Float
19.45MRevenue (TTM)
$2.58BEBITDA (TTM)
$492.89MFree Cashflow (TTM)
$223.75MPricing
Analyst Ratings
The price target is $352.80 and the stock is covered by 5 analysts.
Buy
1
Hold
4
Sell
0
Information
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Its Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes and food testing regimes. The Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are primarily sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
8,030
Scientific & Technical Instr.
Health Care
Identifier
ISIN
Primary Ticker